Literature DB >> 11481616

CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver.

Y Shimizu1, H Murata, Y Kashii, K Hirano, H Kunitani, K Higuchi, A Watanabe.   

Abstract

It is not fully understood how antigen-specific or-nonspecific T cells migrate into the liver in various liver diseases. Macrophage inflammatory protein (MIP)-3alpha is a chemokine that is expressed mostly in the liver, and the receptor CCR6 is reported to be expressed on memory T cells. In the present study, we focused on the expression of CCR6 on T cells from peripheral blood (PB) and inflamed liver, and analyzed the involvement of MIP-3alpha and CCR6 in the immunopathogenesis of liver diseases. Intrahepatic T cells showed significantly (P <.0001) higher percentages of CCR6(+)CD4(+) T cells compared with PB, which is significantly (P =.037) correlated with the necroinflammatory response in the liver. Most of intrahepatic CCR6(+)CD4(+) cells were also positive for CCR5, which is known to express on T-helper 1 cells. MIP-3alpha was stained in the cells located near piecemeal necrosis, where dendritic cells (DCs) are often observed, and coculture of activated DCs with apoptotic cells induced MIP-3alpha production from the DCs. These data suggest that MIP-3alpha is produced by periportal DCs and/or macrophages after necroinflammatory response, leading to the recruitment of activated T cells into the liver. This process could be important to augment the local immune response in the livers of various liver diseases. The finding might be important not only for the understanding of immunopathogenesis of liver diseases but also for the therapeutic strategy to control the local immune response in the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481616     DOI: 10.1053/jhep.2001.26631

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.

Authors:  Linda Hammerich; Jörg M Bangen; Olivier Govaere; Henning W Zimmermann; Nikolaus Gassler; Sebastian Huss; Christian Liedtke; Immo Prinz; Sergio A Lira; Tom Luedde; Tania Roskams; Christian Trautwein; Felix Heymann; Frank Tacke
Journal:  Hepatology       Date:  2013-12-23       Impact factor: 17.425

2.  FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis.

Authors:  Hongming Miao; Yang Zhang; Zhongyan Lu; Liqing Yu; Lixia Gan
Journal:  Mol Endocrinol       Date:  2012-01-12

3.  CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.

Authors:  Silvia Affò; Oriol Morales-Ibanez; Daniel Rodrigo-Torres; José Altamirano; Delia Blaya; Dianne H Dapito; Cristina Millán; Mar Coll; Jorge M Caviglia; Vicente Arroyo; Juan Caballería; Robert F Schwabe; Pere Ginès; Ramón Bataller; Pau Sancho-Bru
Journal:  Gut       Date:  2014-01-10       Impact factor: 23.059

4.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

5.  Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma.

Authors:  Xiao-Peng Zhang; Zhi-Juan Hu; Ai-Hong Meng; Guo-Chen Duan; Qing-Tao Zhao; Jing Yang
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

6.  CCL20 Is Associated with Neurodegeneration Following Experimental Traumatic Brain Injury and Promotes Cellular Toxicity In Vitro.

Authors:  Christopher C Leonardo; James Musso; Mahasweta Das; Derrick D Rowe; Lisa A Collier; Shyam Mohapatra; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2012-08-09       Impact factor: 6.829

7.  Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Mathias Wagner; Christina Weber; Bianca Kruse; Katja Kempf; Jochen König; Bettina Rau; Martin Schilling
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  CCL20/CCR6 expression profile in pancreatic cancer.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Pirus Ghadjar; Mathias Wagner; Henner Grimm; Benjamin Vicinus; Christoph Justinger; Stefan Graeber; Martin K Schilling
Journal:  J Transl Med       Date:  2010-05-10       Impact factor: 5.531

9.  Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.

Authors:  Alessia Omenetti; Wing-Kin Syn; Youngmi Jung; Heather Francis; Alessandro Porrello; Rafal P Witek; Steve S Choi; Liu Yang; Marlyn J Mayo; M Eric Gershwin; Gianfranco Alpini; Anna Mae Diehl
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

10.  Substance P regulates macrophage inflammatory protein 3alpha/chemokine C-C ligand 20 (CCL20) with heme oxygenase-1 in human periodontal ligament cells.

Authors:  S-K Lee; S-H Pi; S-H Kim; K-S Min; H-J Lee; H-S Chang; K-H Kang; H-R Kim; H-I Shin; S-K Lee; E-C Kim
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.